What is this test?
This test measures the level of osteocalcin in blood. Osteocalcin is a major protein found in bone. It is used to help evaluate bone formation disorders. This test is used when a secondary malignant neoplasm of the bone is suspected. It may also be used for postmenopausal women who are at risk for osteoporosis.
What are other names for this test?
- Bone g1a protein measurement
Why do I need this test?
Laboratory tests may be done for many reasons. Tests are performed for routine health screenings or if a disease or toxicity is suspected. Lab tests may be used to determine if a medical condition is improving or worsening. Lab tests may also be used to measure the success or failure of a medication or treatment plan. Lab tests may be ordered for professional or legal reasons. You may need this test if you have:
- Bone metastasis
When and how often should I have this test?
When and how often laboratory tests are done may depend on many factors. The timing of laboratory tests may rely on the results or completion of other tests, procedures, or treatments. Lab tests may be performed immediately in an emergency, or tests may be delayed as a condition is treated or monitored. A test may be suggested or become necessary when certain signs or symptoms appear.
Due to changes in the way your body naturally functions through the course of a day, lab tests may need to be performed at a certain time of day. If you have prepared for a test by changing your food or fluid intake, lab tests may be timed in accordance with those changes. Timing of tests may be based on increased and decreased levels of medications, drugs or other substances in the body.
The age or gender of the person being tested may affect when and how often a lab test is required. Chronic or progressive conditions may need ongoing monitoring through the use of lab tests. Conditions that worsen and improve may also need frequent monitoring. Certain tests may be repeated to obtain a series of results, or tests may need to be repeated to confirm or disprove results. Timing and frequency of lab tests may vary if they are performed for professional or legal reasons.
How should I get ready for the test?
Before having blood collected, tell the person drawing your blood if you are allergic to latex. Tell the healthcare worker if you have a medical condition or are using a medication or supplement that causes excessive bleeding. Also tell the healthcare worker if you have felt nauseated, lightheaded, or have fainted while having blood drawn in the past.
Fast before the test.
Tell the person doing the test if you are pregnant.
How is the test done?
When a blood sample from a vein is needed, a vein in your arm is usually selected. A tourniquet (large rubber strap) may be secured above the vein. The skin over the vein will be cleaned, and a needle will be inserted. You will be asked to hold very still while your blood is collected. Blood will be collected into one or more tubes, and the tourniquet will be removed. When enough blood has been collected, the healthcare worker will take the needle out.
How will the test feel?
The amount of discomfort you feel will depend on many factors, including your sensitivity to pain. Communicate how you are feeling with the person doing the test. Inform the person doing the test if you feel that you cannot continue with the test.
During a blood draw, you may feel mild discomfort at the location where the blood sample is being collected.
What should I do after the test?
After a blood sample is collected from your vein, a bandage, cotton ball, or gauze may be placed on the area where the needle was inserted. You may be asked to apply pressure to the area. Avoid strenuous exercise immediately after your blood draw. Contact your healthcare worker if you feel pain or see redness, swelling, or discharge from the puncture site.
What are the risks?
Blood: During a blood draw, a hematoma (blood-filled bump under the skin) or slight bleeding from the puncture site may occur. After a blood draw, a bruise or infection may occur at the puncture site. The person doing this test may need to perform it more than once. Talk to your healthcare worker if you have any concerns about the risks of this test.
What are normal results for this test?
Laboratory test results may vary depending on your age, gender, health history, the method used for the test, and many other factors. If your results are different from the results suggested below, this may not mean that you have a disease. Contact your healthcare worker if you have any questions. The following are considered to be normal results for this test:
- Adult male: 3-13 nanograms/mL (3-13 micrograms/L) 
- Adult premenopausal female: 0.4-8.2 nanograms/mL (0.4-8.2 micrograms/L) 
- Adult postmenopausal female: 1.5-11 nanograms/mL (1.5-11 micrograms/L) 
- Children, 2 to 17 years: 2.8-41 nanograms/mL (2.8-41 micrograms/L) 
- Neonates: 20-40 nanograms/L (20-40 micrograms/L) 
- In adult males, circadian variations result in a 5- to 10-nanograms/mL fluctuation in osteocalcin levels over a 24-hour period. Circulating levels are lowest in late afternoon and peak nocturnally .
- Serum osteocalcin (OC) assays lack standardization because different assays recognize different molecular fragments . OC levels on the same serum sample, measured at different laboratories, can vary by more than 4 fold. More consistent results can be obtained if the OC level is expressed as a percentage of serum OC in normal individuals .
What might affect my test results?
- Results increased in :
- Adolescent growth spurts (range 40-80 nanograms/mL in boys)
- Chronic renal failure
- Results decreased in :
What follow up should I do after this test?
Ask your healthcare worker how you will be informed of the test results. You may be asked to call for results, schedule an appointment to discuss results, or notified of results by mail. Follow up care varies depending on many factors related to your test. Sometimes there is no follow up after you have been notified of test results. At other times follow up may be suggested or necessary. Some examples of follow up care include changes to medication or treatment plans, referral to a specialist, more or less frequent monitoring, and additional tests or procedures. Talk with your healthcare worker about any concerns or questions you have regarding follow up care or instructions.
Where can I get more information?
- National Osteoporosis Foundation - http://www.nof.org
- National Institute of Arthritis and Musculoskeletal and Skin Disease - http://www.niams.nih.gov
 Seregni E, Martinetti A, Ferrari L, et al: Clinical utility of biochemical marker of bone remodelling in patients with bone metastases of solid tumors. Q J Nucl Med 2001; 45(1):7-17.
 Craciun AM, Vermeer C, Eisenwiener HG, et al: Evaluation of a bead-based enzyme immunoassay for the rapid detection of osteocalcin in human serum. Clin Chem 2000; 46(2):252-257.
 American College of Obstetricians and Gynecologists (ACOG): ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. ACOG Practice Bulletin 2004; No. 50:203-216.
 American Association of Clinical Endocrinologists (AACE): Medical Guidelines for Clinical Practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract 2003; 9:545-564.
 Garnero P, Mulleman D, Munoz F, et al: Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study. J Bone Miner Res 2003; 18(10):1789-1794.
 National Osteoporosis Foundation (NOF): Physician's Guide to Prevention and Treatment of Osteoporosis. National Osteoporosis Foundation. Washington, D.C.. 2003. Available from URL: http://www.nof.org/_vti_bin/shtml.dll/physguide/index.htm. As accessed Oct. 11, 2004.
 Brown JP, Josse RG, & Scientific Advisory Council of the Osteoporosis Society of Canada: 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002; 167(10 Suppl):S1-S34.
 Bauer DC, Sklarin PM, Stone KL, et al: Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures. J Bone Miner Res 1999; 14(8):1404-1410.
 Tietz NW (Ed): Clinical Guide to Laboratory Tests, 3rd ed. W. B. Saunders, Philadelphia, PA, 1995.
 Gundberg CM, Hauschka PV, Lian JB, et al: Osteocalcin: isolation, characterization, and detection. Methods Enzymol 1984; 107:516-544.
 Watts NB: Clinical utility of biochemical markers of bone remodeling. Clin Chem 1999; 45(8 Pt 2):1359-1368.
 Diaz Diego EM, Guerrero R, & de la Piedra C: Six osteocalcin assays compared. Clin Chem 1994; 40(11 Pt 1):2071-2077.
 Delmas PD, Christiansen C, Mann KG, et al: Bone Gla protein (osteocalcin) assay standardization report. J Bone Miner Res 1990; 5(1):5-11.
Last Updated: 11/4/2014